CD163 and neoplasm: The level of CD163+ macrophages, which are associated with the immunosuppressive tumor microenvironment, was lower in responders (3.47 (3.35–6.20)%) compared to non-responders (6.77 (4.42–9.99)%), yet this difference did not reach statistical significance either (p = 0.0849).